paper-with-me

Papers

Precision medicine as a control problem: Using simulation and deep reinforcement learning to discover adaptive, personalized multi-cytokine therapy for sepsis

2018-02-08 · Brenden K. Petersen, Jiachen Yang, Will S. Grathwohl, Chase Cockrell, Claudio Santiago, Gary An, Daniel M. Faissol

Sepsis is a life-threatening condition affecting one million people per year in the US in which dysregulation of the body's own immune system causes damage to its tissues, resulting in a 28 - 50% mortality rate. Clinical trials for sepsis treatment over the last 20 years have failed to produce a single currently FDA approved drug treatment. In this study, we attempt to discover an effective cytokine mediation treatment strategy for sepsis using a previously developed agent-based model that simulates the innate immune response to infection: the Innate Immune Response agent-based model (IIRABM). Previous attempts at reducing mortality with multi-cytokine mediation using the IIRABM have failed to reduce mortality across all patient parameterizations and motivated us to investigate whether adaptive, personalized multi-cytokine mediation can control the trajectory of sepsis and lower patient mortality. We used the IIRABM to compute a treatment policy in which systemic patient measurements are used in a feedback loop to inform future treatment. Using deep reinforcement learning, we identified a policy that achieves 0% mortality on the patient parameterization on which it was trained. More importantly, this policy also achieves 0.8% mortality over 500 randomly selected patient parameterizations with baseline mortalities ranging from 1 - 99% (with an average of 49%) spanning the entire clinically plausible parameter space of the IIRABM. These results suggest that adaptive, personalized multi-cytokine mediation therapy could be a promising approach for treating sepsis. We hope that this work motivates researchers to consider such an approach as part of future clinical trials. To the best of our knowledge, this work is the first to consider adaptive, personalized multi-cytokine mediation therapy for sepsis, and is the first to exploit deep reinforcement learning on a biological simulation.

📄 PDF Abstract BibTeX arXiv:1802.10440

Code (0)

등록된 구현이 없습니다.

Tasks

Deep Reinforcement Learningreinforcement-learningReinforcement LearningReinforcement Learning (RL)

Similar Papers 제목 키워드 기반

Network modeling methods for precision medicine

2021-04-19 · Elio Nushi, Victor-Bogdan Popescu, Jose Angel Sanchez Martin, Sergiu Ivanov 외

We discuss in this survey several network modeling methods and their applicability to precision medicine. We review several network centrality methods (degree centrality, closeness centrality, eccentricity centrality, be…

Optimal personalised treatment computation through in silico clinical trials on patient digital twins

2021-06-20 · Stefano Sinisi, Vadim Alimguzhin, Toni Mancini, Enrico Tronci 외

In Silico Clinical Trials (ISTC), i.e., clinical experimental campaigns carried out by means of computer simulations, hold the promise to decrease time and cost for the safety and efficacy assessment of pharmacological t…

On the improvement of model-predictive controllers

2023-08-29 · L. Féret, A. Gepperth, S. Lambeck

This article investigates synthetic model-predictive control (MPC) problems to demonstrate that an increased precision of the internal prediction model (PM) automatially entails an improvement of the controller as a whol…

modelModel Predictive ControlReinforcement Learning (RL)

Precision Medicine as an Accelerator for Next Generation Cognitive Supercomputing

2018-04-29 · Edmon Begoli, Jim Brase, Bambi DeLaRosa, Penelope Jones 외

In the past several years, we have taken advantage of a number of opportunities to advance the intersection of next generation high-performance computing AI and big data technologies through partnerships in precision med…

Estimation and Optimization of Composite Outcomes

2017-11-28 · Daniel J. Luckett, Eric B. Laber, Michael R. Kosorok

There is tremendous interest in precision medicine as a means to improve patient outcomes by tailoring treatment to individual characteristics. An individualized treatment rule formalizes precision medicine as a map from…